Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | F3 | P13726 | 2/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | MGAM | O43451 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | SI | P14410 | 3/20 | 0.49 |
| ▸ | MGAM2 | Q2M2H8 | 3/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 3/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10061353 | 0.89 | MMP8 (0.56) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL10061349 | 0.88 | CYP2C9 (0.65) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL10061379 | 0.82 | PSMB5 (0.39) | EGFRCYP1A2MMP8MAPTHPGD | |
| SCHEMBL13341570 | 0.81 | CYP1A2 (0.60) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL608180 | 0.80 | CYP2C9 (0.63) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL10061368 | 0.80 | CYP2C9 (0.63) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL10061371 | 0.74 | MGAM (0.39) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL10061358 | 0.72 | CYP2C9 (0.48) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL5585182 | 0.70 | CYP2C9 (1.00) | CYP2C9F3HSD11B1MGAMGAA | |
| SCHEMBL14473217 | 0.70 | CYP2C9 (1.00) | CYP2C9F3HSD11B1MGAMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120040976-A1 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040976-A1 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | L1CAM, LY96, GMFG | CYP2C9 4875/4885F3 4825/4885HSD11B1 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.